Bank of America’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,000
Closed -$63K 7706
2025
Q3
$63K Buy
+8,000
New +$56.9K ﹤0.01% 6771
2025
Q2
Sell
-75,000
Closed -$612K 8479
2025
Q1
$612K Hold
75,000
﹤0.01% 5546
2024
Q4
$707K Buy
+75,000
New +$780K ﹤0.01% 5300
2022
Q4
Sell
-40,000
Closed -$418K 8283
2022
Q3
$418K Hold
40,000
﹤0.01% 5534
2022
Q2
$430K Buy
40,000
+27,500
+220% +$226K ﹤0.01% 5542
2022
Q1
$118K Buy
12,500
+5,000
+67% +$46.9K ﹤0.01% 6768
2021
Q4
$87K Buy
+7,500
New +$83.6K ﹤0.01% 6941
2018
Q2
Sell
-159,700
Closed -$2.4M 7155
2018
Q1
$2.4M Buy
159,700
+115,800
+264% +$1.76M ﹤0.01% 3748
2017
Q4
$632K Buy
43,900
+5,900
+16% +$81.1K ﹤0.01% 4782
2017
Q3
$573K Buy
+38,000
New +$503K ﹤0.01% 4880
2017
Q1
Sell
-49,500
Closed -$246K 7048
2016
Q4
$246K Buy
+49,500
New +$343K ﹤0.01% 5223
2016
Q2
Sell
-200,000
Closed -$1.69M 7193
2016
Q1
$1.69M Buy
+200,000
New +$1.42M ﹤0.01% 3714
2015
Q4
Sell
-68,200
Closed -$954K 7339
2015
Q3
$954K Buy
68,200
+58,200
+582% +$913K ﹤0.01% 4358
2015
Q2
$142K Buy
+10,000
New +$120K ﹤0.01% 5416

Other funds holding FOLD

Bank of America's FOLD Position: Q1 2026 in Review

Bank of America increased its Amicus Therapeutics (FOLD) stake by 13% in Q1 2026, buying an estimated $6.61M and bringing the position to 3,899,490 shares worth $56.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Bank of America first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Bank of America held 3,899,490 shares of Amicus Therapeutics worth $56.4M as of Q1 2026.
  • Bank of America bought 461,249 Amicus Therapeutics shares in Q1 2026, an estimated $6.61M.
  • Amicus Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1510 holding.
  • Bank of America first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.